News | Digital Pathology | August 23, 2019

Philips Signs Agreement to Create Taiwan's First Fully Digitalized Pathology Department

Philips IntelliSite Pathology Solution adopted by Taiwan’s leading academic medical and teaching center Taipei Veterans General Hospital

Philips Signs Agreement to Create Taiwan's First Fully Digitalized Pathology Department

August 23, 2019 – Philips announced that Taipei Veterans General Hospital (TPVGH) will utilize the Philips IntelliSite Pathology Solution to transform its pathology tissue examination to digital diagnostics. By allowing tissue samples to be remotely viewed within a virtual pathology network across hospital locations, the Philips IntelliSite Pathology Solution will help TPVGH to establish Taiwan’s first fully digitalized pathology department, with the aim of enhancing patient safety and improving the quality of diagnoses, thereby leading to better patient outcomes.

Cancer is the leading cause of death in Taiwan. Pathology plays a critical role in the detection and diagnosis of a wide variety of diseases, including cancer. Tissue samples (biopsies) are examined to determine if tissue cells are malignant and consequently to guide treatment decisions. Speedy diagnosis and effective personalized treatment have a significant impact on patients and their families.

Pathological review of patient tissue has historically been done using a microscope. Using the Philips IntelliSite Pathology Solution with the Ultra-Fast Scanner (UFS), TPVGH will now be able to digitize tissue samples so that pathologists can review, interpret, analyze and share digital images. The Image Management System (IMS) that is part of the Philips IntelliSite Pathology Solution allows them to instantly consult colleagues or conveniently present images during multidisciplinary team meetings, without the need to physically transport pathology slides or tissue samples.

In addition to clinical use, the digital images will be stored in image repositories and used to teach pathology students or used for medical research, including cancer research.

Philips IntelliSite Pathology Solution is designed for in-vitro diagnostic purposes, helping pathologists to review and interpret digital images of surgical pathology slides prepared from formalin-fixed paraffin-embedded (FFPE) tissue samples. It has market access clearance in more than fifty countries, including recent market clearance in Taiwan.

For more information: www.usa.philips.com/healthcare

Related Content

Shimadzu Medical Systems USA, a leading manufacturer of advanced medical X-ray imaging systems, has announced that the Trinias unity edition product line has been awarded a contract from Vizient, Inc., a healthcare performance improvement company, effective Sept. 1, 2021.
News | X-Ray | September 17, 2021
September 17, 2021 — Shimadzu Medical Systems USA, a leading manufacturer of advanced medical...
Revised guidelines for lung cancer screening eligibility are perpetuating disparities for racial/ethnic minorities, according to a new study in Radiology.

Getty Images

News | Lung Imaging | September 15, 2021
September 15, 2021 — Revised guidelines for...
Plan to attend RSNA21 at McCormick Place Chicago, Nov. 28 – Dec. 2, 2021

Getty Images

News | RSNA | September 13, 2021
September 13, 2021 — The Radiological Society of North America (RSNA) today announced highlights of the Technical Exh
New recommendations will help provide more reliable, reproducible results for MRI-based measurements of cartilage degeneration in the knee, helping to slow down disease and prevent progression to irreversible osteoarthritis, according to a special report published in the journal Radiology

Knee cartilage compartments with anatomic labels implemented in lateral (left side), central (middle), and medial (right side) MRI obtained with an intermediate weighted fat-saturated fast-spin-echo sequence (top row) and a spin-lattice relaxation time constant in rotating frame (T1r) magnetization-prepared angle-modulated partitioned k-space spoiled gradient echo snapshots sequence (bottom row, T1r maps). Study was performed without administration of intravenous gadolinium-based contrast material. The lateral femur (LF)/medial femur (MF) and lateral tibia (LT)/medial tibia (MT) can be further divided into subcompartments on the basis of meniscus anatomy according to Eckstein et al. P = patella, T = trochlea.  Chalian et al, Radiology 2021 301; 7 ©RSNA 2021

News | Magnetic Resonance Imaging (MRI) | September 10, 2021
September 10, 2021 — New recommendations will help provide more reliable, reproducible results for...
Insignia Medical Systems, a leading UK-based enterprise imaging provider, announced it has been acquired by Intelerad Medical Systems, a global leader in medical image management solutions. The deal signals an important step in expanding next-generation imaging solutions and resources to help modernise hospital trusts across the UK. 

Getty Images

News | Radiology Business | September 08, 2021
September 8, 2021 — Insignia Medical Systems, a leadi
First-of-its-kind, power-assisted Free Motion telescoping column reduces lift force by up to 70 percent to significantly reduce musculoskeletal stress and strain injuries that may occur over the course of an X-ray technologist’s career
News | Digital Radiography (DR) | September 01, 2021
September 1, 2021 — GE Healthcare introduced the...
Expert medical organizations caution that evidence-based ordering of medically necessary imaging exams should not be denied due to widely disagreed upon radiation dose levels tracked in some electronic health record systems (EHRs).
News | Radiation Dose Management | August 17, 2021
August 17, 2021 — Expert medical organizations caution that evidence-based ordering of medically necessary imaging ex
#coronavirus #COVID19 #pandemic #RSNA21 will require all attendees and exhibitors to show proof of #vaccination and wear a #mask

Getty Images

News | RSNA | August 12, 2021
August 12, 2021 — RSNA 2021 will require proof of CO...